BCWORLD PHARM. Co. Ltd (200780) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.43 Billion ≈ $968.52K USD) by net assets (₩72.50 Billion ≈ $49.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can BCWORLD PHARM. Co. Ltd fund operations to measure how many days the company can operate on defensive assets alone.

BCWORLD PHARM. Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how BCWORLD PHARM. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BCWORLD PHARM. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jullundur Motor Agency (Delhi) Limited NSE:JMA	0.048x
YOC AG F:YOC	0.206x
Altech Chemicals Ltd F:A3Y	N/A
Alpha Modus Holdings, Inc NASDAQ:AMOD	0.090x
Tali Resources Ltd AU:TR2	N/A
SCGM Bhd KLSE:7247	-0.031x
Primech Holdings Ltd. Ordinary Shares NASDAQ:PMEC	0.192x
4Sight Holdings Ltd JSE:4SI	0.014x

Annual Cash Flow Conversion Efficiency for BCWORLD PHARM. Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of BCWORLD PHARM. Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market value of BCWORLD PHARM. Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩76.67 Billion ≈ $51.96 Million	₩4.04 Billion ≈ $2.74 Million	0.053x	-60.64%
2023-12-31	₩81.64 Billion ≈ $55.33 Million	₩10.94 Billion ≈ $7.41 Million	0.134x	+54.84%
2022-12-31	₩79.55 Billion ≈ $53.91 Million	₩6.88 Billion ≈ $4.66 Million	0.087x	+1237.07%
2021-12-31	₩81.46 Billion ≈ $55.20 Million	₩-619.83 Million ≈ $-420.05K	-0.008x	+85.94%
2020-12-31	₩101.69 Billion ≈ $68.92 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.054x	-143.45%
2019-12-31	₩97.24 Billion ≈ $65.90 Million	₩12.11 Billion ≈ $8.21 Million	0.125x	+110.10%
2018-12-31	₩90.09 Billion ≈ $61.05 Million	₩5.34 Billion ≈ $3.62 Million	0.059x	-39.05%
2017-12-31	₩81.23 Billion ≈ $55.05 Million	₩7.90 Billion ≈ $5.35 Million	0.097x	+2848.61%
2016-12-31	₩73.88 Billion ≈ $50.06 Million	₩243.66 Million ≈ $165.13K	0.003x	-97.47%
2015-12-31	₩67.40 Billion ≈ $45.68 Million	₩8.78 Billion ≈ $5.95 Million	0.130x	--

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$23.70 Million

₩34.96 Billion KRW

Market Cap Rank

#24582 Global

#1745 in Korea

Share Price

₩3420.00

Change (1 day)

-2.29%

52-Week Range

₩3420.00 - ₩5870.00

All Time High

₩30700.49